Anil Duggal

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial

Christina Fanola, Christian T. Ruff, Sabina A. Murphy et al. · Journal of the American Heart Association · 2018 · 151 citations · Full text

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

Robert M. Califf, Mitradev Boolell, Steven M. Haffner et al. · American Heart Journal · 2008 · 100 citations

Metabolic Syndrome, Non-pharmacological Intervention, Diabetes Management +5

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Frits I. Mulder, Nick van Es, Noémie Kraaijpoel et al. · Thrombosis Research · 2019 · 73 citations

Thrombosis, Pulmonary Embolism, Venous Thrombosis +11

Complementary feeding at 4 versus 6 months of age for preterm infants born at less than 34 weeks of gestation: a randomised, open-label, multicentre trial

Shuchita Gupta, Ramesh Agarwal, Kailash Chandra Aggarwal et al. · The Lancet Global Health · 2017 · 50 citations · Full text

Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin

Robert P. Giugliano, Christian T. Ruff, Natalia S. Rost et al. · Stroke · 2014 · 49 citations · Full text